MENU

CBT Stock Tickeron detected bearish Stock Pattern: Head-and-Shoulders Top CBT on September 15, 2025, netting in a 7.34% gain over 3 weeks

A.I.dvisor
at Tickeron.com
Loading...
+7.34% Gain from a Successful pattern Head-and-Shoulders Top
CBT - Cabot Corp
Tickeron
Ticker: CBT
Company: Cabot
Gain from shorting: +7.34%
Confirmed: 09/15/25
Succeeded: 10/06/25
Total length: 25 days
On September 11, 2025, A.I.dvisor detected a Head-and-Shoulders Top Pattern (Bearish) for Cabot Corp (CBT, $81.47). 4 days later, on September 15, 2025, A.I.dvisor confirmed the Bearish pattern, setting a target price of the stock. On October 06, 2025, the stock hit the target price of $74.38 – resulting in a gain for traders who shorted the stock on the pattern detection date.

CBT in downward trend: 10-day moving average broke below 50-day moving average on September 25, 2025

The 10-day moving average for CBT crossed bearishly below the 50-day moving average on September 25, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

CBT moved below its 50-day moving average on September 19, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CBT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for CBT entered a downward trend on October 15, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 10 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

CBT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.364) is normal, around the industry mean (4.538). P/E Ratio (8.959) is within average values for comparable stocks, (79.270). CBT's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.173). Dividend Yield (0.026) settles around the average of (0.031) among similar stocks. P/S Ratio (0.981) is also within normal values, averaging (141.204).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 86, placing this stock slightly better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. CBT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

View a ticker or compare two or three
CBT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. CBT showed earnings on August 04, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a supplier of organic chemicals

Industry ChemicalsSpecialty

Profile
Fundamentals
Details
Industry
Industrial Specialties
Address
Two Seaport Lane
Phone
+1 617 345-0100
Employees
4300
Web
https://www.cabotcorp.com